SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-057063
Filing Date
2018-11-02
Accepted
2018-11-02 16:32:47
Documents
40
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv505137_10q.htm 10-Q 561723
2 EXHIBIT 31.1 tv505137_ex31-1.htm EX-31.1 10256
3 EXHIBIT 31.2 tv505137_ex31-2.htm EX-31.2 10301
4 EXHIBIT 32.1 tv505137_ex32-1.htm EX-32.1 4063
5 EXHIBIT 32.2 tv505137_ex32-2.htm EX-32.2 3981
  Complete submission text file 0001144204-18-057063.txt   3475366

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cik0001651407-20180930.xml EX-101.INS 812322
7 XBRL TAXONOMY EXTENSION SCHEMA cik0001651407-20180930.xsd EX-101.SCH 29782
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cik0001651407-20180930_cal.xml EX-101.CAL 17860
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cik0001651407-20180930_def.xml EX-101.DEF 196178
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cik0001651407-20180930_lab.xml EX-101.LAB 203697
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cik0001651407-20180930_pre.xml EX-101.PRE 218169
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 181157487
SIC: 2834 Pharmaceutical Preparations